TLSI
TriSalus Life Sciences, Inc.
TLSI lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
TLSI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Weak | |
| Unavailable |
TLSI's revenue is currently stable, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
TLSI PE Valuation
TLSI has no meaningful PE right now: it lost money over the past year.
TLSI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect TLSI's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
TLSI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2025 | -$1.16 | +$6.21 |
TLSI is still losing money, but far less than before: $0.50 per share over the past year, against $7.37 at its worst in mid-2024.
TLSI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $12.9M | +11% |
| Q2 2026 | $11.4M | +1.7% |
| Q1 2026 | $8.9M | -2.9% |
| Q4 2025 | $13.2M | +60% |
| Q3 2025 | $11.6M | +57% |
| Q2 2025 | $11.2M | +52% |
| Q1 2025 | $9.2M | +42% |
| Q4 2024 | $8.3M | +44% |
TLSI's revenue is growing: $13M last quarter, up 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -60% | +18 points |
| Q2 2026 | -86% | -21 points |
| Q1 2026 | -95% | -15 points |
| Q4 2025 | -25% | +67 points |
| Q3 2025 | -78% | +41 points |
| Q2 2025 | -65% | +46 points |
| Q1 2025 | -80% | +101 points |
| Q4 2024 | -92% | +155 points |
TLSI's operating margin was −60% last quarter, up 18 points from the same quarter a year ago.
TLSI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$5.4M | -$1.4M |
| Q2 2026 | -$10.2M | -$3M |
| Q1 2026 | -$6.6M | -$1.4M |
| Q4 2025 | -$2.5M | +$3.2M |
| Q3 2025 | -$3.9M | +$7.1M |
| Q2 2025 | -$7.2M | +$6.3M |
| Q1 2025 | -$5.3M | +$5.7M |
| Q4 2024 | -$5.8M | +$3.5M |
TLSI has burned cash in almost every quarter: −$25M over the past year, against −$22M the year before.
TLSI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +177K shares |
| 1 year | +105% | +29.9M shares |
TLSI has 58M diluted shares, up 105% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
TLSI Net Leverage
TLSI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
TLSI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.3 | Neutral |
| Stochastic | 5.4 | Oversold |
TLSI's weekly RSI is 32 (neutral) and its Stochastic is 5 (oversold).
TLSI PE vs Healthcare Sector
TLSI has no meaningful PE right now: it lost money over the past year.
TLSI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.68 | 32% below |
| 20 week MA | $4.35 | 42% below |
| 50 week MA | $4.63 | 46% below |
| 100 week MA | $4.86 | 48% below |
| 200 week MA | $6.25 | 60% below |
TLSI is in a downtrend: it's below all five of its weekly moving averages, and 60% below its 200-week average.
TLSI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $10.3 | $9.97 | -3.4% |
| 2022 | $9.97 | $10.0 | +0.6% |
| 2023 | $10.0 | $8.45 | -16% |
| 2024 | $8.45 | $4.84 | -43% |
| 2025 | $4.84 | $6.87 | +42% |
| 2026 YTD | $6.87 | $2.52 | -63% |
TLSI has finished lower in three of the last five years. It's down 63% so far in 2026.